4.6 Article

Residual pain in rheumatoid arthritis: Is it a real problem?

Journal

AUTOIMMUNITY REVIEWS
Volume 22, Issue 11, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.autrev.2023.103423

Keywords

Rheumatoid arthritis; Chronic pain; Residual pain; Fibromyalgia; Nociception; Sensitization

Categories

Ask authors/readers for more resources

Pain is a significant issue in rheumatoid arthritis (RA), and inflammation, neuroendocrine responses, cytokines, and the JAK-STAT pathway play a role in its development. Residual pain may persist even after achieving remission, potentially involving non-inflammatory mechanisms and central sensitization. Fibromyalgia syndrome (FMS) is prevalent in RA patients and needs to be identified and diagnosed. JAK inhibitors have shown pain-reducing effects in RA patients independently of their anti-inflammatory properties.
Pain is a significant issue in rheumatoid arthritis (RA) and can have a negative impact on patients' quality of life. Despite optimal control of inflammatory disease, residual chronic pain remains a major unmet medical need in RA. Pain in RA can be secondary to inflammation but can also generate neuroendocrine responses that initiate neurogenic inflammation and enhance cytokine release, leading to persistent hyperalgesia. In addition to well-known cytokines such as TNF alpha and IL-6, other cytokines and the JAK-STAT pathway play a role in pain modulation and inflammation. The development of chronic pain in RA involves processes beyond inflammation or structural damage. Residual pain is often observed in patients even after achieving remission or low disease activity, suggesting the involvement of non-inflammatory and central sensitization mechanisms. Moreover, fibromyalgia syndrome (FMS) is prevalent in RA patients and may contribute to persistent pain. Factors such as depression, sleep disturbance, and pro-inflammatory cytokines may contribute to the development of fibromyalgia in RA. It is essential to identify and diagnose concomitant FMS in RA patients to better manage their symptoms. Further research is needed to unravel the complexities of pain in RA. Finally, recent studies have shown that JAK inhibitors effectively reduce residual pain in RA patients, suggesting pain-reducing effects in-dependent of their anti-inflammatory properties.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available